Literature DB >> 27569712

Frailty and Sarcopenia as Predictors of Adverse Health Outcomes in Persons With Diabetes Mellitus.

Anthony Liccini1, Theodore K Malmstrom2.   

Abstract

OBJECTIVES: Diabetes mellitus is associated with premature aging, and chronic diabetes is associated with significant physical and cognitive complications. We aimed to examine frailty and sarcopenia rates and 6-month health outcomes in a clinic-based sample of patients with diabetes.
DESIGN: This study was an observational study. Participants were recruited from June 2014 to August 2014, and follow-up was conducted 6 months after day of screening.
SETTING: Participants were recruited at outpatient endocrinology, geriatric, and internal medicine clinics affiliated with Saint Louis University in St. Louis, Missouri. PARTICIPANTS: Participants were persons with diabetes mellitus ages 50 to 90. MEASUREMENTS: Frailty and sarcopenia were identified using the FRAIL and SARC-F screens, respectively. A chart review of the patient's health record was performed on day of screening and at follow-up. A 6-month phone questionnaire was performed to evaluate health outcomes. Logistic regressions were used to evaluate health outcomes.
RESULTS: A total of 198 persons with diabetes were recruited. Of the sample, 32.3% of sample was nonfrail, 38.9% was prefrail, and 28.8% was frail; 29.3% of the sample was identified to have sarcopenia. Prefrail [odds ratio (OR) 2.92, 95% confidence interval (CI) 1.15-7.42; P = .025] and frail (OR 4.70, 95% CI 1.67-13.19; P = .003) participants were more likely to be hospitalized overnight at 6-month follow-up. Frail (OR 3.57 95% CI 1.27-10.04; P = .016) participants were more likely to have a new activities of daily living (ADL) disability at follow-up; this association was not present for prefrail participants (OR 1.30, 95% CI .50-3.37; P = .59). Participants with sarcopenia were more likely to be hospitalized (OR 3.80, 95% CI 1.67-8.61; P = .001) and to have a new ADL disability (OR 4.24, 95% CI 1.76-10.18; P = .001) at 6-month follow-up.
CONCLUSIONS: Among clinic patients with diabetes mellitus ages 50-90 year old, frailty and sarcopenia prevalence is high, and both syndromes are predictors of being hospitalized overnight and new ADL disability after 6 months.
Copyright © 2016 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FRAIL; Frailty; SARC-F; diabetes mellitus; sarcopenia

Mesh:

Year:  2016        PMID: 27569712     DOI: 10.1016/j.jamda.2016.07.007

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  32 in total

1.  Editorial: Frailty, Comorbidity, and COPD.

Authors:  E Charbek; J R Espiritu; R Nayak; J E Morley
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

2.  Editorial: Weight Loss is a Major Cause of Frailty.

Authors:  B Fougère; J E Morley
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

3.  Editorial: Orthogeriatrics and Hip Fractures.

Authors:  A M Sanford; J E Morley; A McKee
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

4.  Frailty, Diabetes, and Mortality in Middle-Aged African Americans.

Authors:  S Chode; T K Malmstrom; D K Miller; J E Morley
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

5.  Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME® trial.

Authors:  Pedro Monteiro; Richard M Bergenstal; Elvira Toural; Silvio E Inzucchi; Bernard Zinman; Stefan Hantel; Sanja Giljanovic Kiš; Stefan Kaspers; Jyothis T George; David Fitchett
Journal:  Age Ageing       Date:  2019-11-01       Impact factor: 10.668

6.  Editorial: Screening for Sarcopenia.

Authors:  J E Morley; A M Sanford
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

7.  Probable sarcopenia: associations with common geriatric syndromes and comorbidities in Turkish geriatric patients from a university hospital.

Authors:  Duygu Erbas Sacar; Cihan Kılıc; Meryem Merve Oren; Tugba Erdogan; Serdar Ozkok; Caglar Ozer Aydın; Nezahat Muge Catikkas; Mehmet Akif Karan; Gulistan Bahat
Journal:  Eur Geriatr Med       Date:  2022-08-27       Impact factor: 3.269

8.  Validation of a multi-frequency bioelectrical impedance analysis device for the assessment of body composition in older adults with type 2 diabetes.

Authors:  Assaf Buch; Arie Ben-Yehuda; Vanessa Rouach; Andrea B Maier; Yona Greenman; Elena Izkhakov; Naftali Stern; Roy Eldor
Journal:  Nutr Diabetes       Date:  2022-10-20       Impact factor: 4.725

Review 9.  Frailty and sarcopenia in elderly.

Authors:  John E Morley
Journal:  Wien Klin Wochenschr       Date:  2016-09-26       Impact factor: 1.704

Review 10.  Screening Tools for Sarcopenia.

Authors:  Hiroki Nishikawa; Akira Asai; Shinya Fukunishi; Toshihisa Takeuchi; Masahiro Goto; Takeshi Ogura; Shiro Nakamura; Kazuki Kakimoto; Takako Miyazaki; Shuhei Nishiguchi; Kazuhide Higuchi
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.